# Osisko Metals Incorporated (OM.TO) fundamentals

Data as of 2026-11-04. TSX, Canada. Sector: Basic Materials / Mining & Metals. Price C$1.40, market value C$1.3 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Osisko Metals Incorporated reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 27.5×**. The shares trade at 27.5× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -4.6%** (5-yr avg -27.6%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -29.1%**. Return on equity is negative because earnings are negative.

## Growth
- **EPS growth (1 yr): 0.0%**. Earnings per share rose 0.0%.

## Financial health
- **Debt to equity: 0.57**. Debt is 0.57 times equity, moderate leverage.
- **Current ratio: 0.91** (quick 0.91). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Osisko Metals Incorporated does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 157.4%** (YTD 82.9%, 3-mo -12.6%). The shares are up 157.4% over twelve months including dividends.
- **From 52-week high: -29.6%** (211.1% above the low). Trading 30% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 33**. An RSI of 33 is neutral.
- **Beta (1 yr): 2.32** (volatility 70%). Beta of 2.32 against the S&P/TSX Composite: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OM.TO · Page: https://foliofundamentals.com/stocks/om.to

Not investment advice.